Goldman’s latest rating for MLTX stock

In a filing, MoonLake Immunotherapeutics revealed its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $0.26 million on Feb 29 ’24. In the deal valued at $55.89 per share,4,740 shares were sold. As a result of this transaction, Santos da Silva Jorge now holds 2,982,814 shares worth roughly $129.75 million. Then, […]

MLTX stock rated a Neutral by Goldman

NUE

In a filing, MoonLake Immunotherapeutics revealed its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $0.26 million on Feb 29 ’24. In the deal valued at $55.89 per share,4,740 shares were sold. As a result of this transaction, Santos da Silva Jorge now holds 2,982,814 shares worth roughly $140.94 million. Then, […]

Analyzing Stock On Your Own: MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (NASDAQ:MLTX) does about 97.50K shares in volume on a normal day but saw 297168 shares change hands in Friday trading. The company now has a market cap of 901.81M USD. Its current market price is $17.95, marking a decrease of -0.33% compared to the previous close of $18.01. The 52 week high reached […]